ACERUS OTC Stock Volatility

ASPCF
 Stock
  

USD 2.21  0.00  0.00%   

ACERUS PHARMACEUTICALS secures Sharpe Ratio (or Efficiency) of -0.0841, which signifies that the company had -0.0841% of return per unit of risk over the last 3 months. Macroaxis approach to foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. ACERUS PHARMACEUTICALS CORP exposes twenty-four different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm ACERUS PHARMACEUTICALS coefficient of variation of (1,094), and Mean Deviation of 6.03 to double-check the risk estimate we provide.
  
Refresh
ACERUS PHARMACEUTICALS OTC Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of ACERUS daily returns, and it is calculated using variance and standard deviation. We also use ACERUS's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of ACERUS PHARMACEUTICALS volatility.

720 Days Market Risk

Abnormally volatile

Chance of Distress

High

720 Days Economic Sensitivity

Moves totally opposite to the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as ACERUS PHARMACEUTICALS can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of ACERUS PHARMACEUTICALS at lower prices. For example, an investor can purchase ACERUS stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of ACERUS PHARMACEUTICALS's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with ACERUS PHARMACEUTICALS

0.8MKKGYMerck Kgaa ADRPairCorr
0.79MKGAFMerck Kgaa DmPairCorr

Moving against ACERUS PHARMACEUTICALS

0.84PPDPPD IncPairCorr

ACERUS PHARMACEUTICALS Market Sensitivity And Downside Risk

ACERUS PHARMACEUTICALS's beta coefficient measures the volatility of ACERUS otc stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents ACERUS otc stock's returns against your selected market. In other words, ACERUS PHARMACEUTICALS's beta of -1.13 provides an investor with an approximation of how much risk ACERUS PHARMACEUTICALS otc stock can potentially add to one of your existing portfolios.
Let's try to break down what ACERUS's beta means in this case. As the market becomes more bullish, returns on owning ACERUS PHARMACEUTICALS are expected to decrease slowly. On the other hand, during market turmoil, ACERUS PHARMACEUTICALS is expected to outperform it slightly.
3 Months Beta |Analyze ACERUS PHARMACEUTICALS Demand Trend
Check current 90 days ACERUS PHARMACEUTICALS correlation with market (DOW)

ACERUS Beta

    
  -1.13  
ACERUS standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  12.09  
It is essential to understand the difference between upside risk (as represented by ACERUS PHARMACEUTICALS's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of ACERUS PHARMACEUTICALS stock's daily returns or price. Since the actual investment returns on holding a position in ACERUS PHARMACEUTICALS stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in ACERUS PHARMACEUTICALS.

ACERUS PHARMACEUTICALS OTC Stock Volatility Analysis

Volatility refers to the frequency at which ACERUS PHARMACEUTICALS stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with ACERUS PHARMACEUTICALS's price changes. Investors will then calculate the volatility of ACERUS PHARMACEUTICALS's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of ACERUS PHARMACEUTICALS's volatility:

Historical Volatility

This type of stock volatility measures ACERUS PHARMACEUTICALS's fluctuations based on previous trends. It's commonly used to predict ACERUS PHARMACEUTICALS's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for ACERUS PHARMACEUTICALS's current market price. This means that the stock will return to its initially predicted market price.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Developed by Larry Williams, the Weighted Close is the average of ACERUS PHARMACEUTICALS high, low and close of a chart with the close values weighted twice. It can be used to smooth an indicator that normally takes only ACERUS PHARMACEUTICALS closing price as input.
.

ACERUS PHARMACEUTICALS Projected Return Density Against Market

Assuming the 90 days horizon ACERUS PHARMACEUTICALS CORP has a beta of -1.1319 . This suggests
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ACERUS PHARMACEUTICALS or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ACERUS PHARMACEUTICALS stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ACERUS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. ACERUS PHARMACEUTICALS is significantly underperforming DOW.
 Predicted Return Density 
      Returns 
ACERUS PHARMACEUTICALS's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how ACERUS PHARMACEUTICALS stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Company's Stock Price Volatility?

Several factors can influence a company's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

ACERUS PHARMACEUTICALS OTC Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ACERUS PHARMACEUTICALS or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ACERUS PHARMACEUTICALS stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ACERUS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Assuming the 90 days horizon the coefficient of variation of ACERUS PHARMACEUTICALS is -1188.99. The daily returns are distributed with a variance of 146.28 and standard deviation of 12.09. The mean deviation of ACERUS PHARMACEUTICALS CORP is currently at 6.23. For similar time horizon, the selected benchmark (DOW) has volatility of 1.42
α
Alpha over DOW
-1.3
β
Beta against DOW-1.13
σ
Overall volatility
12.09
Ir
Information ratio -0.08

ACERUS PHARMACEUTICALS OTC Stock Return Volatility

ACERUS PHARMACEUTICALS historical daily return volatility represents how much ACERUS PHARMACEUTICALS stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The firm shows 12.0948% volatility of returns over 90 . By contrast, DOW inherits 1.449% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
      Timeline 

About ACERUS PHARMACEUTICALS Volatility

Volatility is a rate at which the price of ACERUS PHARMACEUTICALS or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of ACERUS PHARMACEUTICALS may increase or decrease. In other words, similar to ACERUS's beta indicator, it measures the risk of ACERUS PHARMACEUTICALS and helps estimate the fluctuations that may happen in a short period of time. So if prices of ACERUS PHARMACEUTICALS fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

ACERUS PHARMACEUTICALS Investment Opportunity

ACERUS PHARMACEUTICALS CORP has a volatility of 12.09 and is 8.34 times more volatile than DOW. 96  of all equities and portfolios are less risky than ACERUS PHARMACEUTICALS. Compared to the overall equity markets, volatility of historical daily returns of ACERUS PHARMACEUTICALS CORP is higher than 96 () of all global equities and portfolios over the last 90 days. Use ACERUS PHARMACEUTICALS CORP to protect your portfolios against small market fluctuations. The otc stock experiences a normal downward fluctuation but is a risky buy. Check odds of ACERUS PHARMACEUTICALS to be traded at $2.19 in 90 days. . Let's try to break down what ACERUS's beta means in this case. As the market becomes more bullish, returns on owning ACERUS PHARMACEUTICALS are expected to decrease slowly. On the other hand, during market turmoil, ACERUS PHARMACEUTICALS is expected to outperform it slightly.

Good diversification

The correlation between ACERUS PHARMACEUTICALS CORP and DJI is Good diversification for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ACERUS PHARMACEUTICALS CORP and DJI in the same portfolio, assuming nothing else is changed.

ACERUS PHARMACEUTICALS Additional Risk Indicators

The analysis of ACERUS PHARMACEUTICALS's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in ACERUS PHARMACEUTICALS's investment and either accepting that risk or mitigating it. Along with some common measures of ACERUS PHARMACEUTICALS stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance(0.12)
Market Risk Adjusted Performance0.9678
Mean Deviation6.03
Coefficient Of Variation(1,094)
Standard Deviation11.75
Variance138.04
Information Ratio(0.08)
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

ACERUS PHARMACEUTICALS Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Alphabet vs. ACERUS PHARMACEUTICALS
Novan vs. ACERUS PHARMACEUTICALS
Arca Biopharma vs. ACERUS PHARMACEUTICALS
RENEWI PLC vs. ACERUS PHARMACEUTICALS
MITIE GROUP vs. ACERUS PHARMACEUTICALS
Solo Brands vs. ACERUS PHARMACEUTICALS
Vmware vs. ACERUS PHARMACEUTICALS
GLAXOSMITHKLINE PLC vs. ACERUS PHARMACEUTICALS
Cyclacel Pharmaceuti vs. ACERUS PHARMACEUTICALS
Seneca Foods vs. ACERUS PHARMACEUTICALS
BP PLC vs. ACERUS PHARMACEUTICALS
Liquidia Corp vs. ACERUS PHARMACEUTICALS
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against ACERUS PHARMACEUTICALS as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. ACERUS PHARMACEUTICALS's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, ACERUS PHARMACEUTICALS's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to ACERUS PHARMACEUTICALS CORP.
Please continue to Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Is ACERUS PHARMACEUTICALS's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACERUS PHARMACEUTICALS. If investors know ACERUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACERUS PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
18.5 M
Quarterly Revenue Growth YOY
2.34
Return On Assets
-0.65
Return On Equity
-22.42
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.